Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S362100
Reexamination Certificate
active
07872039
ABSTRACT:
Novel 3-aminoindazoles of the formula (I) are SGK inhibitors and can be used for the treatment of SGK-induced diseases and conditions, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, generally in fibrosis and inflammatory processes of any type.
REFERENCES:
patent: 2971842 (1961-02-01), Moore et al.
patent: 2996467 (1961-08-01), Hawley et al.
patent: 7297709 (2007-11-01), Dai et al.
patent: 2004/0110956 (2004-06-01), Lesuisse et al.
patent: 12 80 878 (1968-10-01), None
patent: WO 02/22601 (2002-03-01), None
patent: WO 02/096873 (2002-12-01), None
patent: WO 03/051847 (2003-06-01), None
patent: WO 03/064397 (2003-08-01), None
patent: WO 03/097610 (2003-11-01), None
patent: WO 03/097610 (2003-11-01), None
patent: WO 2004/022544 (2004-03-01), None
patent: WO 2004/112719 (2004-12-01), None
patent: WO 2004/113303 (2004-12-01), None
patent: WO 2004/113304 (2004-12-01), None
patent: WO 2005/011681 (2005-02-01), None
West, Anthony R., Solid State Chemistry and Its Applications, Wiley, New York, 1988, 358.
Boehmer, et al., Post-translational Regulation of EAAT2 Function by Co-expressed Ubiquitin Ligase Nedd4-2 Is Impacted by SGK Kinases, J. of Neurochem., 97, 911-921 (2006).
Vippagunta et. al., Advanced Drug Delivery Reviews 48 (2001) 3-26.
Maren Hertweck et al., C. Elegans SGK-1 Is the Critical Component in The AKT/PKB Kinase Complex to Control Stress Response And Life Span, Developmental Cell, Apr. 2004, pp. 577-588, vol. 6, Cell Press.
Polymorphism: in the pharmaceutical industry (edited by Ralf Hilfker; 2006 Wiley-VCH), Chapter 8, The Importance of Solvates, by U. J. Griesser, pp. 211-222 (hereinafter Griesser).
Beier Norbert
Burgdorf Lars Thore
Dorsch Dieter
Gericke Rolf
Lang Florian
Leeser Erich A
Merck Patent Gesellschaft
Millen White Zelano & Branigan P.C.
Wilson James O
LandOfFree
3-aminoindazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-aminoindazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aminoindazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2703707